Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 8.

Han, Sang Hoon; Kumar, D; Ferreira, V H; Egli, A; Hirsch, H H; Weisser, M; Garzoni, C; van Delden, C; Bochud, P Y; Manuel, O; Meylan, P; Boggian, K; Husain, S; Mueller, N J; Humar, A; Swiss Transplant Cohort Study (2017). Human microRNA responses predict cytomegalovirus replication following solid organ transplantation. Journal of Infectious Diseases, 215(4):537-546.

Meinel, D M; Kuehl, R; Zbinden, R; Boskova, V; Garzoni, C; Fadini, D; Dolina, M; Blümel, B; Weibel, T; Tschudin-Sutter, S; Widmer, A F; Bielicki, J A; Dierig, A; Heininger, U; Konrad, R; Berger, A; Hinic, V; Goldenberger, D; Blaich, A; Stadler, T; Battegay, M; Sing, A; Egli, A (2016). Outbreak investigation for toxigenic Corynebacterium diphtheriae wound infections in refugees from Northeast Africa and Syria in Switzerland and Germany by whole genome sequencing. Clinical Microbiology and Infection, 22(12):1003.e1-1003.e8.

Bucheli, E; Kralidis, G; Boggian, K; Cusini, A; Garzoni, C; Manuel, O; Meylan, P R A; Mueller, N J; Khanna, N; van Delden, C; Berger, C; Koller, M T; Weisser, M (2014). Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss Transplant Cohort Study. Transplant Infectious Disease, 16(1):26-36.

Gonzalez, A; Schmitter, K; Hirsch, H H; Garzoni, C; van Delden, C; Boggian, K; Mueller, N J; Berger, C; Villard, J; Manuel, O; Meylan, P; Stern, M; Hess, C (2014). KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients. Genes and immunity, 15(7):495-499.

Manuel, O; Kralidis, G; Mueller, N J; Hirsch, H H; Garzoni, C; van Delden, C; Berger, C; Boggian, K; Cusini, A; Koller, M T; Weisser, M; Pascual, M; Meylan, P R (2013). Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients. American Journal of Transplantation, 13(9):2402-2410.

Scherrer, A U; von Wyl, V; Böni, J; Yerly, S; Klimkait, T; Bürgisser, P; Garzoni, C; Hirschel, B; Cavassini, M; Battegay, M; Vernazza, P L; Bernasconi, E; Ledergerber, B; Günthard, H F (2011). Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. JAIDS Journal of Acquired Immune Deficiency Syndromes, 57(1):24-31.

Khanna, N; Elzi, L; Mueller, N J; Garzoni, C; Cavassini, M; Fux, C A; Vernazza, P; Bernasconi, E; Battegay, M; Hirsch, H H (2009). Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clinical Infectious Diseases, 48(10):1459-1466.

Khanna, N; Wolbers, M; Mueller, N J; Garzoni, C; Du Pasquier, R A; Fux, C A; Vernazza, P; Bernasconi, E; Viscidi, R; Battegay, M; Hirsch, H H (2009). JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. Journal of Virology, 83(9):4404-4411.

This list was generated on Sat Jan 20 07:14:54 2018 CET.